Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China · Delayed Price · Currency is CNY 56.19
-0.49 (-0.86%)
Nov 21, 2025, 3:04 PM CST
Haisco Pharmaceutical Group Company Description
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China.
The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases.
The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016.
Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.
Haisco Pharmaceutical Group Co., Ltd.
| Country | China |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5,337 |
| CEO | Xiu Lian Fan |
Contact Details
Address: No. 17 Sanxiang Avenue Shannan, 856000 China | |
| Phone | 86 89 3783 4865 |
| Website | haisco.com |
Stock Details
| Ticker Symbol | 002653 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100001BC7 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xiu Lian Fan | MD, GM and Director |
| Peng Duan | Chief Financial Officer |
| Meng Wang | Deputy GM and Board Secretary |
| Han Bing Liu | Human Resources Manager |